PLG and thrombophilia: Also, any antifibrinolytic agents that inhibit fibrin degradation can be employed to promote hypercoagulation, like tranexamic acid, which acts by binding to the surface of plasminogen or plasmin, preventing it from binding to and degrading fibrin, and was used to induce acute hypercoagulation in rat models by a single intragastric administration [69].